Evaluating Pharmacogenomic Variants for Cardiology Therapeutics

NCT04702113 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
300
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Cipherome, Inc.

Collaborators